Primary Central Nervous System ALK Positive Anaplastic Large Cell Lymphoma with Predominantly Leptomeningeal Involvement in an Adult
3
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
A 31-year-old Korean male presented with altered consciousness and severe headache. Brain MRI delineated focal leptomeningeal enhancement without any intracerebral lesions. Diagnosis was made based on a brain biopsy showing anaplastic large cell lymphoma (ALCL), immunohistochemical stains revealing positivity for anaplastic lymphoma kinase (ALK) and an absence of involvement in any other organs;specifically, the primary central nervous system ALK+ALCL. Complete remission was achieved following 5 cycles of systemic chemotherapy with a high dose of Methotrexate and a simultaneous 7 cycles of intrathecal triple chemotherapy. Diagnosis of primary leptomeningeal ALK+ALCL is challenging given its rarity and non-specific symptoms along with non-pathognomonic radiologic findings. We present the first case of primary leptomeningeal ALK-positive ALCL where the clinical course, pathologic characteristics and treatment modality are described as well as a review of literature.
Abstract
A 31-year-old Korean male presented with altered consciousness and severe headache. Brain MRI delineated focal leptomeningeal enhancement without any intracerebral lesions. Diagnosis was made based on a brain biopsy showing anaplastic large cell lymphoma (ALCL), immunohistochemical stains revealing positivity for anaplastic lymphoma kinase (ALK) and an absence of involvement in any other organs;specifically, the primary central nervous system ALK+ALCL. Complete remission was achieved following 5 cycles of systemic chemotherapy with a high dose of Methotrexate and a simultaneous 7 cycles of intrathecal triple chemotherapy. Diagnosis of primary leptomeningeal ALK+ALCL is challenging given its rarity and non-specific symptoms along with non-pathognomonic radiologic findings. We present the first case of primary leptomeningeal ALK-positive ALCL where the clinical course, pathologic characteristics and treatment modality are described as well as a review of literature.
참고문헌 (21)
- Stein H, "The expression of the Hodgkin’s disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: evidence that Reed-Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells", Blood, 66, pp.848~858 (1985)
- Jaffe ES, "Tumors of haematopoietic and lymphoid tissues" (2001), IARC Press
- Campo E, "The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications", Blood, 117, pp.5019~5032 (2011)
- Swerdlow SH, "WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues" (2008), IARC Press
- Karikari IO, "Primary cerebral ALK-1-positive anaplastic large cell lymphoma in a child. Case report and literature review", Pediatr Neurosurg, 43, pp.516~521 (2007)
- Penny RJ, "Ki-1-positive large cell lymphomas, a heterogenous group of neoplasms. Morphologic, immunophenotypic, genotypic, and clinical features of 24 cases", Cancer, 68, pp.362~373 (1991)
- Falini B, "ALK+ lymphoma: clinico-pathological findings and outcome", Blood, 93, pp.2697~2706 (1999)
- Abdulkader I, "Primary anaplastic large cell lymphoma of the central nervous system", Hum Pathol, 30, pp.978~981 (1999)
- George DH, "Primary anaplastic large cell lymphoma of the central nervous system: prognostic effect of ALK-1 expression", Am J Surg Pathol, 27, pp.487~493 (2003)
- Ponzoni M, "Primary brain CD30+ ALK1+ anaplastic large cell lymphoma (‘ALKoma’): the first case with a combination of ‘not common’ variants", Ann Oncol, 13, pp.1827~1832 (2002)
- Merlin E, "Primary leptomeningeal ALK+ lymphoma in a 13-year-old child", J Pediatr Hematol Oncol, 30, pp.963~967 (2008)
- Ozkaynak MF, "Favorable outcome of primary CNS anaplastic large cell lymphoma in an immunocompetent patient", J Pediatr Hematol Oncol, 31, pp.128~130 (2009)
- Shiota M, "Anaplastic large cell lymphomas expressing the novel chimeric protein p80NPM", ALK: a distinct clinicopathologic entity, 1995, pp.86, 1954~1960
- Villano JL, "Age, gender, and racial differences in incidence and survival in primary CNS lymphoma", Br J Cancer, 105, pp.1414~1418 (2011)
- Buxton N, "Primary Ki-1-positive T-cell lymphoma of the brain in a child", Pediatr Neurosurg, 29, pp.250~252 (1998)
- Goldbrunner R, "Primary Ki-1-positive T-cell lymphoma of the brain--an aggressive subtype of lymphoma: case report and review of the literature", Surg Neurol, 46, pp.37~41 (1996)
- Paulus W, "Large cell anaplastic (KI-1) brain lymphoma of T-cell genotype", Hum Pathol, 25, pp.1253~1256 (1994)
- Lachance DH, "Primary leptomeningeal lymphoma: report of 9 cases, diagnosis with immunocytochemical analysis, and review of the literature", Neurology, 41, pp.95~100 (1991)
- Taga T, "Pediatric primary leptomeningeal lymphoma treated without cranial radiotherapy", Pediatr Blood Cancer, 48, pp.477~478 (2007)
- Felice MS, "Diagnosis and successful treatment of childhood primary leptomeningeal lymphoma", Med Pediatr Oncol, 34, pp.361~363 (2000)
- Shah AC, "Treatment of primary CNS lymphoma with high-dose methotrexate in immunocompetent pediatric patients", Pediatr Blood Cancer, 55, pp.1227~1230 (2010)